LOW DOSE HMG-COA REDUCTASE INHIBITOR WITH REDUCED SIDE EFFECTS

摘要

The present invention relates to pharmaceutical formulations for lowering cholesterol in a human subject comprising (a) a HMG-CoA reductase inhibitor, (b) at least one of SNAC, SNAD, 5CNAC, 4CNAB, 4M0AC, 4HPO, 5-PPA, 3-TBA, 2-HPOD, 7-OPHA, 3-HPSB, 4- IBOA and 3-FPSB (c) optionally CoEnzyme Q and (d) optionally, a pharmaceutically acceptable excipient.